Neurotech Devices Market Size, Share, and Trends 2024 to 2034

The global market size is calculated at USD 16.66 billion in 2025 and is forecasted to reach around USD 55.79 billion by 2034, accelerating at a CAGR of 14.37% from 2025 to 2034. The North America market size surpassed USD 8.09 billion in 2024 and is expanding at a CAGR of 14.30% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

  • Last Updated : April 2025
  • Report Code : 4027
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Neurotech Devices Market 

5.1. COVID-19 Landscape: Neurotech Devices Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Neurotech Devices Market, By Product Type

8.1. Neurotech Devices Market Revenue and Volume, by Product Type

8.1.1 Neuroprosthetics

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Neural stimulators

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Neurorehabilitation

8.1.3.1. Market Revenue and Volume Forecast

Chapter 9. Global Neurotech Devices Market, By Condition

9.1. Neurotech Devices Market Revenue and Volume, by Condition

9.1.1. Pain Management

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Parkinson's Disease

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Cerebral Palsy

9.1.3.1. Market Revenue and Volume Forecast

9.1.4. Cognitive Disorders

9.1.4.1. Market Revenue and Volume Forecast

9.1.5. Epilepsy

9.1.5.1. Market Revenue and Volume Forecast

9.1.6. Incontinence

9.1.6.1. Market Revenue and Volume Forecast

9.1.7. Migraine

9.1.7.1. Market Revenue and Volume Forecast

9.1.8. Hearing Conditions

9.1.8.1. Market Revenue and Volume Forecast

9.1.9. Chronic Pain

9.1.9.1. Market Revenue and Volume Forecast

9.1.10. Spinal Cord Injury

9.1.10.1. Market Revenue and Volume Forecast

9.1.11. Stroke Traumatic Brain Injury Others

9.1.11.1. Market Revenue and Volume Forecast

9.1.12. Traumatic Brain Injury

9.1.12.1. Market Revenue and Volume Forecast

9.1.13. Others

9.1.13.1. Market Revenue and Volume Forecast

Chapter 10. Global Neurotech Devices Market, By End-user 

10.1. Neurotech Devices Market Revenue and Volume, by End-user

10.1.1. Hospitals

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Ambulatory Surgical Center

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Diagnostic Centers

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Ambulatory Surgical Center

10.1.4.1. Market Revenue and Volume Forecast

10.1.5. Home Care Facilities

10.1.5.1. Market Revenue and Volume Forecast

Chapter 11. Global Neurotech Devices Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Volume Forecast, by Product Type

11.1.2. Market Revenue and Volume Forecast, by Condition

11.1.3. Market Revenue and Volume Forecast, by End-user

11.1.4. U.S.

11.1.4.1. Market Revenue and Volume Forecast, by Product Type

11.1.4.2. Market Revenue and Volume Forecast, by Condition

11.1.4.3. Market Revenue and Volume Forecast, by End-user

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Volume Forecast, by Product Type

11.1.5.2. Market Revenue and Volume Forecast, by Condition

11.1.5.3. Market Revenue and Volume Forecast, by End-user

11.2. Europe

11.2.1. Market Revenue and Volume Forecast, by Product Type

11.2.2. Market Revenue and Volume Forecast, by Condition

11.2.3. Market Revenue and Volume Forecast, by End-user

11.2.4. UK

11.2.4.1. Market Revenue and Volume Forecast, by Product Type

11.2.4.2. Market Revenue and Volume Forecast, by Condition

11.2.4.3. Market Revenue and Volume Forecast, by End-user

11.2.5. Germany

11.2.5.1. Market Revenue and Volume Forecast, by Product Type

11.2.5.2. Market Revenue and Volume Forecast, by Condition

11.2.5.3. Market Revenue and Volume Forecast, by End-user

11.2.6. France

11.2.6.1. Market Revenue and Volume Forecast, by Product Type

11.2.6.2. Market Revenue and Volume Forecast, by Condition

11.2.6.3. Market Revenue and Volume Forecast, by End-user

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Volume Forecast, by Product Type

11.2.7.2. Market Revenue and Volume Forecast, by Condition

11.2.7.3. Market Revenue and Volume Forecast, by End-user

11.3. APAC

11.3.1. Market Revenue and Volume Forecast, by Product Type

11.3.2. Market Revenue and Volume Forecast, by Condition

11.3.3. Market Revenue and Volume Forecast, by End-user

11.3.4. India

11.3.4.1. Market Revenue and Volume Forecast, by Product Type

11.3.4.2. Market Revenue and Volume Forecast, by Condition

11.3.4.3. Market Revenue and Volume Forecast, by End-user

11.3.5. China

11.3.5.1. Market Revenue and Volume Forecast, by Product Type

11.3.5.2. Market Revenue and Volume Forecast, by Condition

11.3.5.3. Market Revenue and Volume Forecast, by End-user

11.3.6. Japan

11.3.6.1. Market Revenue and Volume Forecast, by Product Type

11.3.6.2. Market Revenue and Volume Forecast, by Condition

11.3.6.3. Market Revenue and Volume Forecast, by End-user

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Volume Forecast, by Product Type

11.3.7.2. Market Revenue and Volume Forecast, by Condition

11.3.7.3. Market Revenue and Volume Forecast, by End-user

11.4. MEA

11.4.1. Market Revenue and Volume Forecast, by Product Type

11.4.2. Market Revenue and Volume Forecast, by Condition

11.4.3. Market Revenue and Volume Forecast, by End-user

11.4.4. GCC

11.4.4.1. Market Revenue and Volume Forecast, by Product Type

11.4.4.2. Market Revenue and Volume Forecast, by Condition

11.4.4.3. Market Revenue and Volume Forecast, by End-user

11.4.5. North Africa

11.4.5.1. Market Revenue and Volume Forecast, by Product Type

11.4.5.2. Market Revenue and Volume Forecast, by Condition

11.4.5.3. Market Revenue and Volume Forecast, by End-user

11.4.6. South Africa

11.4.6.1. Market Revenue and Volume Forecast, by Product Type

11.4.6.2. Market Revenue and Volume Forecast, by Condition

11.4.6.3. Market Revenue and Volume Forecast, by End-user

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Volume Forecast, by Product Type

11.4.7.2. Market Revenue and Volume Forecast, by Condition

11.4.7.3. Market Revenue and Volume Forecast, by End-user

11.5. Latin America

11.5.1. Market Revenue and Volume Forecast, by Product Type

11.5.2. Market Revenue and Volume Forecast, by Condition

11.5.3. Market Revenue and Volume Forecast, by End-user

11.5.4. Brazil

11.5.4.1. Market Revenue and Volume Forecast, by Product Type

11.5.4.2. Market Revenue and Volume Forecast, by Condition

11.5.4.3. Market Revenue and Volume Forecast, by End-user

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Volume Forecast, by Product Type

11.5.5.2. Market Revenue and Volume Forecast, by Condition

11.5.5.3. Market Revenue and Volume Forecast, by End-user

Chapter 12. Company Profiles

12.1. Boston Scientific Corporation

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. BrainCo, Inc

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Cochlear Limited

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Control Bionics, Inc

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. LivaNova PLC

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Medtronic plc

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Nihon Kohden Corporation

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Natus Medical Incorporated

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Integra LifeSciences

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Blackrock Microsystems

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global Neurotech Devices market size is expected to increase USD 55.79 billion by 2033 from USD 14.75 billion in 2024.

The global Neurotech Devices market will register growth rate of 14.37% between 2025 and 2034.

The major players operating in the Neurotech Devices market are Boston Scientific Corporation, BrainCo, Inc, Cochlear Limited, Control Bionics, Inc, LivaNova PLC, Medtronic plc, Nihon Kohden Corporation, Natus Medical Incorporated, Integra LifeSciences, Blackrock Microsystems, NeuroSigma, Inc., NeuroVigil Inc., Neuralink Corp., Abbott Laboratories, Advanced Bionics AG, and Others.

The driving factors of the Neurotech Devices market are the Rising incidence of neurological disorders and rise in awareness about the neurotechnology industr.

North America region will lead the global Neurotech Devices market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client